MBIO — Mustang Bio Balance Sheet
0.000.00%
- $11.21m
- $9.88m
Annual balance sheet for Mustang Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 61.4 | 97.8 | 110 | 75.7 | 6.23 |
Net Total Receivables | 0.019 | 0.015 | 0.05 | 0.036 | 3.88 |
Prepaid Expenses | |||||
Total Current Assets | 63.1 | 99.5 | 112 | 78.9 | 11.3 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 9.13 | 9.12 | 12.1 | 12.3 | 4.81 |
Other Long Term Assets | |||||
Total Assets | 73.4 | 110 | 125 | 92.4 | 17.7 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 7.77 | 9.52 | 10.8 | 15.1 | 15.4 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 21.8 | 11.5 | 12.8 | 46.1 | 17.6 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 51.7 | 98.4 | 112 | 46.3 | 0.123 |
Total Liabilities & Shareholders' Equity | 73.4 | 110 | 125 | 92.4 | 17.7 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |